BREATH TEST FOR DISEASE DETECTION

COVID-19

Breathonix BreFence™ Go COVID-19 Breath Test System has gained Singapore HSA Provisional Approval and Malaysia MOH Approval.

Other Fatal Diseases

Ongoing clinical trials to detect a wide range of diseases including early detection of Lung Cancer, Nasopharyngeal Cancer and Tuberculosis. 

KEY HIGHLIGHTS

Slingshot 2019 MedTech Winner

Breathonix was the MedTech Sector Winner (out of 2400 startups) of Slingshot 2019 competition.

6+ Years of Breath Analysis Research

The technology is developed from 6+ years of breath analysis research.

Backed by Reputable Investors

Funded by Antler and Origgin VC.

COLLABORATION

To the ones who made it possible 

JOIN OUR MISSION

Reimagine Diagnostics with Rapid Breath Test for Disease Detection

LATEST UPDATES

Breathonix is delighted to be chosen as an Urban Innovation Champion at Cities of the Future 2022. Join us on 2 March when we’ll be presenting our company’s story live alongside other Champions shaping tomorrow’s #smartcities ? https://bit.ly/3uLPL8w ?️2 Mar Organised in […]
Zühlke worked with Breathonix to set solid foundations for their solution architecture and identify opportunities through advanced technologies to scale their digital and innovation capabilities. Executive Summary Breathonix’s BreFence™ Go is the first COVID-19 system to receive provisional authorisation from […]
SINGAPORE, 16 July 2021 – Singapore-based firms Accredify and Breathonix today announced their collaboration to supply an on-site COVID-19 rapid-breath test system that issues digital verifiable COVID-19 test results compliant with countries’ international travel and domestic health requirements in less than […]